Skip Navigation LinksHome > Current Issue > Contributor Index

April 15, 2015 - Volume 68 - Issue 5 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Author Name Article
Fatkenheuer, Gerd MD, PhD

Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor–Based Combination Antiretroviral Therapy: The D: A: D Study

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Feng, Liqiang PhD

Simian Immunodeficiency Virus Infection Evades Vaccine-Elicited Antibody Responses to V2 Region

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ferreyra, Cecilia MBBS

Risk Factors and Mortality Associated With Resistance to First-Line Antiretroviral Therapy: Multicentric Cross-sectional and Longitudinal Analyses

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Florence, Eric MD, PhD

Risk Factors for HCV Acquisition Among HIV-Positive MSM in Belgium

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
for the ATHENA national observational cohort and the MOSAIC study

Changes in HIV RNA and CD4 Cell Count After Acute HCV Infection in Chronically HIV-Infected Individuals

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
for the D:A:D study group

Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor–Based Combination Antiretroviral Therapy: The D: A: D Study

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
for the Denver Emergency Department HIV Research Consortium

Brief Report: Validation of a Quantitative HIV Risk Prediction Tool Using a National HIV Testing Cohort

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
for the HPTN 058 Protocol Team

Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine–Naloxone: HIV Prevention Trials Network 058

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Fu, Liping MD

Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine–Naloxone: HIV Prevention Trials Network 058

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Furrer, Hansjakob MD, PhD

Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor–Based Combination Antiretroviral Therapy: The D: A: D Study

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Actions
View